Ahanchian Hamid, Moazzen Nasrin, Sezavar Majid, Khalighi Negar, Khoshkhui Maryam, Aelami Mohammad Hassan, Motevalli Haghi Nasrin Sadat, Rezaei Nima
Allergy Research Center Mashhad University of Medical Sciences Mashhad Iran.
Clinical Research Development Unit of Akbar hospital Mashhad University of medical Sciences Mashhad Iran.
Clin Case Rep. 2020 Dec 8;9(2):755-758. doi: 10.1002/ccr3.3643. eCollection 2021 Feb.
Although presentation of COVID-19 in patients with immunodeficiency could be mild, it should not be missed, while early diagnosis and appropriate treatment can survive infected patients. Because even severe infections in PID patients may be presented with few symptoms and signs, this diagnosis should be considered in those immunocompromised patients who have exacerbating preexisting symptoms.
尽管免疫缺陷患者感染新型冠状病毒肺炎（COVID-19）的症状可能较轻，但仍不应漏诊，早期诊断和适当治疗可使感染患者存活。由于原发性免疫缺陷（PID）患者即使发生严重感染，症状和体征也可能较少，因此对于那些原有症状加重的免疫功能低下患者，应考虑这一诊断。
